Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > December 2012

« Previous month Next month » 2012 Quiz

21-Dec-2012 - Test you knowledge of the key developments in the Outsourcing sector in 2012 with our festive news quiz.

BASF wont extend Pronova offer again

20-Dec-2012 - BASF says it will not extend its offer for pharmaceutical-grade omega-3 supplier Pronova BioPharma ASA beyond new mid-January deadline.

5-minute festive flick

Happy holidays from William Reed Business Media!

19-Dec-2012 - The working year is almost done, time to pause from ‘the business’ and embrace the festive season…go on, give it a big hug. Happy holidays!

New Design!

New Design: OSP's bid to enhance user experience

18-Dec-2012 - Outsourcing-pharma is pleased to showcase its brand new design layout with intuitive navigation and deeper user experience in mind, in an effort to deliver news in an even more efficient way....

S&P predicts Quintiles will win more market share

17-Dec-2012 - Quintiles is likely to benefit from Big Pharma demand for strategic deals and small pharma’s lack of in-house capacity according to S&P.


MaD scientists mull apocalypse’s impact on clinical trials

14-Dec-2012 - The end of the world is likely to have a negative impact on clinical trials according to research published in the journal of the Canadian Medical Association.

ICIG buys Tessenderlo's struggling pharma business

13-Dec-2012 - International Chemical Investors Group (ICIG) has bought Tessenderlo's underperforming European pharmaceutical intermediates and API business.


Catalent signs cell line deal with Japanese CMO

13-Dec-2012 - Catalent Pharma Solutions will supply Japanese CMO Unigen with cell lines under an agreement announced today.

Top CROs discuss new FDA draft guide on preclinical testing for cell therapies

12-Dec-2012 - Leading CROs have welcomed the flexibility of new US FDA preclinical testing guidelines for cellular and gene therapies as a positive first step.

Contract wins show Sweden is emerging CMO hub says Kemwell

12-Dec-2012 - Kemwell AB says new contract from Mercury Pharma is further proof that Sweden is an attractive place for pharmaceutical production.

BASF confident it can get omega-3 to pharma customers whatever the weather

12-Dec-2012 - Last week, BASF officially opened a pharmaceutical grade omega-3 active pharmaceutical ingredient (API) facility on the Isle of Lewis, Scotland that it gained with the acquisition of Equateq earlier this year ....

Latest developments in the CRO space

11-Dec-2012 - Collaborations and expansions dominate’s roundup of developments in the CRO space, with news from Cenduit, Perceptive Informatics, INC Reseach and Spaulding Clinical Research.

Harlan to invest in 2012 thanks to cuts last year

11-Dec-2012 - Harlan Laboratories has followed 2011 cutbacks and consolidation measures with plans to invest and expand its preclinical services site in Itingen, Switzerland.

Quintiles expects to help Alimera sell Iluvien in UK

10-Dec-2012 - Quintiles expects to support Alimera Sciences’ efforts to gain UK approval for a diabetic vision loss treatment already deemed too expensive by NICE.  

More expansion for QPS in Asia through intellim JV

10-Dec-2012 - QPS Holdings has set up a joint venture (JV) partnership with intellim Corporation to set up a new CRO in Japan.

News from CPhI

Aesica says academic partnerships are key for CMOs

06-Dec-2012 - UK CMO Aesica Pharmaceutical says that working with academia to access cutting edge technologies is critical for contractors that want to meet the demands of the modern drug industry.


Chemi Pharmaceutical cries sabotage after licence suspension

06-Dec-2012 - Chemi Pharmaceutical CEO says sabotage by former employee behind accusations of falsified test results that prompted Canadian regulators to suspend license. 

AMRI has biggest supply contract renewed by GE Healthcare

06-Dec-2012 - Contract manufacturing organisation (CMO) AMRI has had its largest commercial supply contract renewed by GE Healthcare.

GDUFA 'self-identification' plan not flawed says SOCMA after FDA extends deadline

05-Dec-2012 - The GDUFA ‘self-identification’ requirement for generic API plants is not a flawed idea says SOCMA’s BDTF after FDA extends registration deadline citing fewer than expected registrations.

GE says techs made at Cardiff lab will lower cell therapy development costs

05-Dec-2012 - GE Healthcare says new cell science lab in Wales will save drugmakers time and money and create more accurate alternatives to animal-based drug toxicity testing models.

New Guidelines by Canadian, UK Team Address "Ethical Challenges" of CRTs

05-Dec-2012 - Researchers say cluster randomized trials (CRTs) present "distinct ethical challenges" and have created 15 "guidelines" to help researchers and ethics committees address them.

News in brief

TFS buys Italian CRO Dimensione Ricerca

05-Dec-2012 - Swedish CRO Trial Form Support International (TFS) has bought Italian counterpart Dimensione Ricerca to strengthen its presence in Southern Europe and key therapeutic areas like oncology.

Covance gets GLP ok from SFDA for China preclinical lab

05-Dec-2012 - Covance says SFDA GLP certification for Shanghai early-phase facility will save sponsors time and money in China and elsewhere.

Icon guidance suggests margin improvement in 2013

04-Dec-2012 - Guidance issued by Icon is at the lower end of consensus estimates but it still suggests that the CROs margins are set to improve.

News in brief

Recipharm adds analytical capacity at Swedish plant

04-Dec-2012 - Swedish CMO Recipharm has added capacity for analytical services and stability studies at its laboratory in Solna, Sweden 

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...